Parliamentary and Scientific Committee

Parliamentary and Scientific Committee

The Parliamentary and Scientific Committee is an all-party forum connecting legislators and researchers to discuss science policy and technology transfer issues affecting the United Kingdom, engaging members from across Parliament of the United Kingdom, House of Commons of the United Kingdom, House of Lords of the United Kingdom, and the research councils alongside institutions such as the Royal Society, the Wellcome Trust, and the University of Oxford. Founded on the eve of World War II amid debates involving figures linked to Winston Churchill, Neville Chamberlain, and industrial actors like Imperial Chemical Industries, the Committee has evolved into a platform for exchanges between parliamentarians, academics, and representatives of bodies including the Engineering and Physical Sciences Research Council, the Medical Research Council, and the Technology Strategy Board.

History

The Committee was established in 1939 following discussions that involved members associated with House of Commons of the United Kingdom factions and scientific advocates connected to institutions such as the Royal Institution, the Royal Society, and the National Physical Laboratory. Early meetings referenced contemporary crises like World War II and drew parallels to advisory arrangements seen during the First World War, invoking figures linked to Winston Churchill, Lord Cherwell, and industrial contributors such as Imperial Chemical Industries. Postwar activity intersected with policy developments shaped by the Attlee ministry and by debates about reconstruction that involved the Ministry of Supply, the Medical Research Council, and the Atomic Energy Authority. In subsequent decades the Committee engaged with topics resonant with the Science and Technology Act 1965, the expansion of the University of Cambridge and University of Manchester, and the rise of private-sector actors like Rolls-Royce Holdings and GlaxoSmithKline in science policy deliberations.

Structure and Membership

The Committee operates as an all-party parliamentary group drawing membership from both the House of Commons of the United Kingdom and the House of Lords of the United Kingdom, with a governing committee and officers often including peers and MPs who have served on select committees such as the Science and Technology Select Committee and the Public Accounts Committee (United Kingdom). Members have included parliamentarians with links to constituencies represented in areas housing institutions like the University of Edinburgh, the University of Manchester, and the University of Birmingham; chairs and officers have been peers, including scientists linked to the Royal Society and administrators formerly of the Medical Research Council and the Engineering and Physical Sciences Research Council. The Committee invites participation from external organisations such as the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, and industry participants like Siemens and Rolls-Royce Holdings, while maintaining formal ties with the Department for Business, Energy and Industrial Strategy and advisory bodies including the Advisory Committee on Business Appointments.

Activities and Functions

The Committee convenes meetings, inquiries, and seminars that bring together parliamentarians, scientists, and stakeholders from organisations such as the Royal Society, the Wellcome Trust, the Institute of Physics, and the Royal Academy of Engineering to deliberate on matters exemplified by debates over genome editing, nuclear power in the United Kingdom, and artificial intelligence. It organises evidence sessions drawing expert witnesses from universities like University College London, the University of Cambridge, and the Imperial College London, and from research councils including the Medical Research Council and the Engineering and Physical Sciences Research Council; sessions often feature representatives from companies such as GlaxoSmithKline and AstraZeneca and NGOs like Cancer Research UK. The Committee facilitates dialogue ahead of parliamentary scrutiny in bodies such as the House of Lords Committee on Science and Technology and the Science and Technology Select Committee, and contributes to policy framing connected to legislation like the Data Protection Act 2018 and initiatives linked to the Industrial Strategy (United Kingdom).

Publications and Reports

Although not a statutory inquiry body, the Committee circulates briefing notes, meeting summaries, and reports prepared in collaboration with organisations such as the Royal Society, the Wellcome Trust, and the Academy of Medical Sciences; these materials are used by MPs and peers preparing contributions to debates in the House of Commons of the United Kingdom and the House of Lords of the United Kingdom. Publications have synthesised evidence on topics parallel to reports by the Science and Technology Committee (House of Commons) and the House of Lords Science and Technology Select Committee, and align with outputs from the National Audit Office and white papers issued by the Department for Business, Energy and Industrial Strategy. The Committee’s briefings have supported parliamentary scrutiny of issues involving institutions like the Atomic Energy Authority, companies such as BP plc, and research funders including the Biotechnology and Biological Sciences Research Council.

Relationships with Parliament and Scientific Community

The Committee occupies a bridging role between elected representatives in the Parliament of the United Kingdom and members of the scientific establishment such as the Royal Society, the Royal Academy of Engineering, and university communities at University of Oxford, University of Cambridge, and Imperial College London. It liaises with select committees including the Science and Technology Select Committee and the Public Accounts Committee (United Kingdom), and with government departments such as the Department for Business, Energy and Industrial Strategy and the Department of Health and Social Care, while fostering links to funders like the Wellcome Trust and the Medical Research Council. Through engagement with industry actors—GlaxoSmithKline, AstraZeneca, Rolls-Royce Holdings—and NGOs—Cancer Research UK, Wellcome Trust—the Committee aims to inform parliamentary debate and enhance informed decision-making on science and technology matters.

Category:All-party parliamentary groups of the United Kingdom